China Grand Enterprises, INC. (hereinafter referred to as CGE), established in 1993, is a joint-stock company, headquartered in Grand Place, Beijing Asian Games Village. As a management investment company, CGE is mainly engaged in pharmaceutical and healthcare, commodity trading, real estate investment, and financial services.
China Grand Enterprises Pharmaceuticals & Healthcare (hereinafter referred to as CGE Healthcare) owns multiple subsidiaries such as Huadong Medicine, Grand Pharmaceutical Group, Lei Yunshang Group and Grand Life Sciences Group. CGE Healthcare is a comprehensive pharmaceutical group with wide therapeutic areas, rich product lines and advanced technology, providing over a thousand drugs and medicines, medical devices, active pharmaceutical ingredients (API), chemical intermediates, health care products and other related pharmaceutical products. Meantime, the company has a professional marketing system and a sales network all over the country, and multiple products have passed the European COS certification and FDA certification and have been exported to many countries and regions.
CGE Healthcare adheres to the business concept of "technology research-based, patients-centered and market-oriented" and has always taken innovation as the strategic focus. New products have been put on the market constantly through the independent R&D platform construction, industry-teaching-research collaborative innovation, and international cooperation, guaranteeing the enterprise's sustainable and rapid development. Through the development of more than 20 years, the enterprise has formed a business model integrating R&D, production and sales, simultaneously developing traditional Chinese medicines, chemical medicines, biological medicines medical devices as well as medical cosmetic, and jointly developing domestic and international markets.
Grand Industrial Holding Co., Ltd was established in June 1994. The company attaches great importance to the R&D and innovation of biopesticides, and firmly adheres to the development strategy of high-tech agriculture. While putting its all effort into the development of bulk commodity trade, the company did not hesitate to combine trading with industrial and high technology, striving to become a large-scale high-tech enterprise that deeply integrates trade, industry, and high technology. Today, the company has more than 30 wholly-owned and holding subsidiaries, and has established business organizations in many countries and regions overseas. Its main business covers the fields of ecological agriculture, oils and fats, and trade.
Grand Real Estate Group (hereinafter referred to as Grand Real Estate) is a nationwide real estate investment group mainly engaged in the construction and operation of commercial complex and also involved in residential development, a holding group company subordinated to China Grand Enterprises, INC. Grand Real Estate invests in Beijing, Heilongjiang, Jilin, Shanxi, Zhejiang, Sichuan, Guizhou, Yunnan, Hainan and other provinces and cities.
Through investment and construction, Grand Real Estate has formed a commercial complex with "Grand Shopping Plaza" as the core, and gradually formed a cohesive and efficient team. The group's team continuously creates new business models by relying on their strong business sense and predictive strategic vision. For example, in 1998, the group invested in the construction of the first shopping center, Heilongjiang Grand Shopping Center which has become a collectivized shopping center through continuous exploration of business opportunities. Besides, "Grand Bay View Hotel" has become a representative famous brand in the industry and has an excellent hotel management and operation team.
Financial service is one of the important investment and development directions of CGE. In recent years, CGE has invested in the establishment of commercial banks, financial leasing, financial industry investment companies and other financial institutions successively. Moreover, CGE will continue to increase investment to achieve greater development in financial services.
Grand Pharma brings heavyweight products to the World Health Expo
Grand Pharma Recognized as a National Technology Innovation Demonstration Enterprise
Globally innovative products Atectura® and Enerzair® developed by Grand Pharma officially enter the domestic market
Accelerating Global Innovation, Opening Ceremony of Grand Pharma Optics Valley R&D Center and Extensive Intervention Production and R&D Platform
SIR-Spheres® Yttrium-90 Microspheres Injections Introduced by Grandpharma Officially Launched in Chinese Market
Yuanda Shuyang's New Production Base for Blood Products Officially Put into Operation